New York Post26d
FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The first medication for obstructive sleep apnea has been approved ... The drug is to be paired with a reduced-calorie diet and increased physical activity, the FDA noted. Sally Seymour, M.D ...
Billed as nonaddictive, new pain pill could soon win FDA approval
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...
San Diego Union-Tribune21d
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration approved Eli Lilly ... which help people shave pounds. The FDA first approved Zepbound to treat obesity in November 2023. Its active ingredient, tirzepatide ...
Medical Xpress23d
FDA approves Tryngolza as adjunct to diet for familial chylomicronemia syndrome
Tryngolza (olezarsen) has been approved by the U.S. Food and Drug ... with a diet including ≤20 g fat per day. Tryngolza is self-administered once monthly via an autoinjector. The FDA approval ...
Onlymyhealth21d
FDA Approves Weight-Loss Drug Zepbound For Obstructive Sleep Apnea
The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound ... The drug is designed to be used alongside a reduced-calorie diet and increased physical activity, offering ...
WebMD29d
FDA Approves Zepbound for Obstructive Sleep Apnea
23, 2024 -- The FDA has approved ... drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Studies have shown that when combined with a low ...
USA Today28d
FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could be used for in adults and children 10 and up. The new drug ...
Hosted on MSN24d
FDA Approves Tryngolza as Adjunct to Diet for Familial Chylomicronemia Syndrome
FRIDAY, Dec. 27, 2024 (HealthDay News) -- Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce ... The FDA approval was based on data ...
Pharmabiz28d
US FDA approves Ionis Pharma’s Tryngolza to treat adults living with familial chylomicronemia syndrome as an adjunct to diet
Ionis Pharmaceuticals, Inc, a biotechnology company that develops RNA-targeted therapeutics, announced that the US Food and Drug Administration (FDA) has approved Tryngolza (olezarsen) as an adjunct ...
Medscape29d
FDA Approves Second Generic Daily GLP-1 Drug for T2D
The US Food and Drug Administration has approved ... with type 2 diabetes (T2D), as an adjunct to diet and exercise. The move follows the FDA’s approval last month of a generic version of ...